Oxycodone naloxone combination clinical trials
How each study uses oxycodone naloxone combination is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the oxycodone naloxone combination studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
7 studies that test it; most in 2014 (2)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 4
Mundipharma Korea Ltd (2) · University of British Columbia (1) · Mundipharma (China) Pharmaceutical Co. Ltd (1) · University of Edinburgh (1) · Medical University of Vienna (1) · Assaf-Harofeh Medical Center (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses oxycodone naloxone combination is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Pain Relief After Corneal Collagen Cross-LinkingNot yet recruitingEarly Phase 1Assaf-Harofeh Medical CenterNCT06212830Written as Targin
- Targin® for Chronic Pain Management in Patients With Spinal Cord InjuryCompletedPhase 4University of British ColumbiaNCT03179475Written as Oxycodone Naloxone Combination
- Efficacy and Safety of Oxycodone/Naloxone (Targin®) in Persistent Moderate to Severe Low Back Pain Following NSAIDs TreatmentCompletedPhase 4Mundipharma Korea LtdNCT03768466Written as Brand Name: Targin®
- OXN PR Tablet 5/2.5 mg and20/10 mg PK Study in Chinese Moderate to Severe Chronic Non-malignant PatientsCompletedPhase 1Mundipharma (China) Pharmaceutical Co. LtdNCT02880475Written as OXN PR tablet
- A Comparison of Targinact vs. Oxycodone on Gut Function After Colorectal SurgeryCompletedPhase 3University of EdinburghNCT02109640Written as Targinact
- A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)CompletedPhase 4Mundipharma Korea LtdNCT01675531Written as Targin
- Oral Oxycodone After Major Cardiac SurgeryCompletedPhase 4Medical University of ViennaNCT01816581Written as Targin